Le Lavoir Limited (BOM:539814)
89.10
-4.65 (-4.96%)
At close: Jul 10, 2026
Le Lavoir Revenue
In the fiscal year ending March 31, 2026, Le Lavoir had annual revenue of 89.50M INR with 173.08% growth. Le Lavoir had revenue of 20.25M in the quarter ending March 31, 2026, with 189.37% growth.
Revenue
89.50M
Revenue Growth
+173.08%
P/S Ratio
3.28
Revenue / Employee
n/a
Employees
n/a
Market Cap
293.57M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 89.50M | 56.72M | 173.08% |
| Mar 31, 2025 | 32.77M | 6.07M | 22.74% |
| Mar 31, 2024 | 26.70M | 5.22M | 24.29% |
| Mar 31, 2023 | 21.48M | 9.25M | 75.57% |
| Mar 31, 2022 | 12.24M | -2.34M | -16.05% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Welcure Drugs and Pharmaceuticals | 3.66B |
| PAOS Industries | 883.74M |
| Tyroon Tea Company | 350.04M |
| Yaan Enterprises | 244.30M |
| National Oxygen | 229.61M |
| Adarsh Plant Protect | 120.37M |
| Skybiotech Healthcare | 74.04M |
| Alfavision Overseas (India) | 19.91M |